Latest filing published 28 May 2018 for Wilson Therapeutics AB, €2.0M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Genghis Lloyd-Harris: trading record in brief
Genghis Lloyd-Harris appears in our data through filings on Wilson Therapeutics AB shares, published by Finansinspektionen. Over a trading history stretching from 18 August 2016 to 23 May 2018, the count stands at 3 filings.
The open-market side counts 2 purchases for €2.5M alongside 1 sale for €2.0M. On balance, insiders were net buyers of €451k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2018: 1 purchase and 1 sale on the market.
On 29 May 2018 came the latest disclosure, an open-market sale for €2.0M in Wilson Therapeutics AB. The last purchase on record was published on 28 May 2018, which is 3,086 days ago. Typically, a trade is published a median of 5 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Genghis Lloyd-Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 90,000 shares@ SEK 232.0081.9% of flowISIN SE0008293674FI:csv-6d016e6d92c4451335d2Canonical exit: 21 Aug 2018 (T+90)
- 90,000 shares@ SEK 47.5018.1% of flowISIN SE0008293674FI:csv-a03cf4663f14f9a5bc01Canonical exit: 16 Nov 2016 (T+90)
2 of 2 declarations